Two food additives with previously unrecognized estrogen-like effects
Scientists in Italy are reporting development and successful use of a fast new method to identify food additives that act as so-called “xenoestrogens” — substances with estrogen-like effects that are stirring international health concerns.
Vegetable-based drug could inhibit melanoma
Compounds extracted from green vegetables such as broccoli and cabbage could be a potent drug against melanoma, according to cancer researchers. Tests on mice suggest that these compounds, when combined with selenium, target tumors more safely and effectively than conventional therapy.
Pediatric Hodgkin’s disease survivors face increased breast cancer risk
Women who as children got radiation treatment for Hodgkin’s disease are almost 40 times more likely than others to develop breast cancer, according to findings from five institutions, including the University of Florida.
Device Aims to Decrease Wait Period for Patients Needing Immunotherapy
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have created a device that significantly decreases the time needed to produce genetically manipulated T cells in preclinical tests for leukemia.
Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer
Unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target. Cancer cells have multiple ways to avoid apoptosis, programmed cell death the means by which organisms deal with defective cells. One defense is to produce quantities of phosphatic acid, a phospholipid constituent of cellular membranes.